Updates

Biotechnology Industry’s Role in Nutrition Enhancement

The biotechnology industry in India has emerged as a significant driver of improvements in both human and animal nutrition by innovating biofortified crops, nutraceuticals, and animal feed supplements. As of 2023, the Indian biotech sector was valued at approximately USD 84 billion with a projected CAGR of 16.5% till 2028 (IBEF 2024). Key stakeholders include the Department of Biotechnology (DBT), Biotechnology Industry Research Assistance Council (BIRAC), Indian Council of Agricultural Research (ICAR), and regulatory bodies such as the Genetic Engineering Appraisal Committee (GEAC) and Food Safety and Standards Authority of India (FSSAI). The sector’s advances address malnutrition and food security challenges by enhancing micronutrient content in crops and improving livestock productivity sustainably.

UPSC Relevance

  • GS Paper III: Science and Technology – Biotechnology applications in agriculture and nutrition, Food processing, and Biotechnology regulation
  • GS Paper II: Polity – Constitutional provisions related to health and environment (Article 47, Environment Protection Act)
  • Essay: Role of emerging technologies in food security and nutrition

Article 47 of the Indian Constitution mandates the State to improve public health, forming the constitutional basis for biotech interventions in nutrition. The Environment Protection Act, 1986 regulates biosafety aspects of genetically engineered organisms. The Genetic Engineering Appraisal Committee (GEAC), constituted under the Rules for Manufacture, Use, Import, Export & Storage of Hazardous Microorganisms Genetically Engineered Organisms or Cells Rules, 1989, is the apex body for approving biotech products including genetically engineered crops and feed additives. The Food Safety and Standards Act, 2006 empowers the FSSAI to set safety standards for food and nutraceutical products, ensuring consumer protection and quality assurance.

Economic Dimensions of Biotech-Driven Nutrition

The Indian nutraceuticals market expanded from USD 4.5 billion in 2019 to USD 7 billion in 2023, growing at 20% annually (FICCI 2023). The animal feed additives market is projected to reach USD 3.5 billion by 2025, driven by probiotics and enzyme supplements that enhance livestock productivity by 12% (CRISIL 2023). Government support includes an allocation of INR 1,500 crore under BIRAC for nutrition-related biotech innovations in 2023-24. India’s exports of biotech-derived nutraceuticals and feed supplements increased by 18% in FY23 (DGCI&S 2023), reflecting growing global demand and competitiveness.

  • Over 70 biofortified crop varieties developed by ICAR have enhanced micronutrient content, aiding reduction of malnutrition (ICAR Annual Report 2023)
  • States adopting biotech biofortified crops reported a 5% decline in malnutrition rates (NFHS-5, 2021-22)
  • BIRAC funded more than 150 startups between 2020-2023 focused on nutrition-related biotech solutions

Key Institutions Driving Biotech Innovations in Nutrition

The Department of Biotechnology (DBT) formulates policies and funds R&D. BIRAC catalyzes public-sector innovation through grants and incubation. ICAR spearheads development of biofortified crops and animal nutrition technologies. FSSAI regulates food and nutraceutical safety standards, while GEAC oversees approvals for genetically engineered products. The National Institute of Nutrition (NIN) conducts research on human nutrition and provides dietary guidelines integrating biotech advances.

Comparative Analysis: India vs United States in Biotech-Driven Nutrition

AspectIndiaUnited States
Regulatory FrameworkFragmented, slow GEAC approval process delaying commercializationFDA’s GRAS (Generally Recognized As Safe) framework enables faster approvals
Market Size (Nutraceuticals)USD 7 billion (2023)USD 50 billion (2023)
Livestock Productivity Gains from Biotech Feed Additives12% increase (CRISIL 2023)~25% increase (USDA Report 2023)
Export Growth Rate (Biotech Nutraceuticals & Feed)18% (FY23)Not publicly comparable but significantly higher volume and value

Challenges and Critical Gaps in India’s Biotech Nutrition Sector

India’s regulatory environment is a bottleneck due to the lengthy and complex GEAC approval process for genetically engineered crops and feed additives, discouraging private investment and delaying market entry. Unlike the US and Brazil, India lacks a unified, expedited approval mechanism for biotech nutrition products. Additionally, public awareness and acceptance of genetically engineered foods and supplements remain low, limiting market penetration. Infrastructure and funding gaps in translational research further constrain commercialization of innovations.

Significance and Way Forward

  • Streamline GEAC and FSSAI approval processes by adopting risk-based, science-driven frameworks similar to FDA’s GRAS to accelerate product commercialization
  • Enhance public-private partnerships and increase funding for startups innovating in biofortification, nutraceuticals, and animal feed supplements
  • Expand ICAR and NIN collaborations to integrate biotech advances into national nutrition programs and dietary guidelines
  • Promote consumer awareness campaigns to build trust in biotech-derived nutrition products
  • Strengthen biosafety and environmental monitoring under the Environment Protection Act to ensure sustainable biotech deployment
📝 Prelims Practice
Consider the following statements about the regulatory framework for biotechnology products in India:
  1. The Genetic Engineering Appraisal Committee (GEAC) is responsible for approving genetically engineered crops and organisms.
  2. The Food Safety and Standards Authority of India (FSSAI) regulates the safety of nutraceuticals and food products.
  3. The Environment Protection Act, 1986, does not cover biosafety regulations related to genetically engineered organisms.

Which of the above statements is/are correct?

  • a1 and 2 only
  • b2 and 3 only
  • c1 and 3 only
  • d1, 2 and 3
Answer: (a)
Statement 1 is correct as GEAC approves genetically engineered crops and organisms. Statement 2 is correct because FSSAI regulates safety standards for food and nutraceuticals. Statement 3 is incorrect since the Environment Protection Act, 1986, governs biosafety aspects related to genetically engineered organisms.
📝 Prelims Practice
Consider the following statements about biofortified crops developed by ICAR:
  1. Biofortified crops are genetically engineered varieties designed to increase micronutrient content.
  2. Over 70 biofortified crop varieties have been developed by ICAR to improve human nutrition.
  3. States adopting biofortified crops have shown a reduction in malnutrition rates.

Which of the above statements is/are correct?

  • a1 and 2 only
  • b2 and 3 only
  • c1 and 3 only
  • d1, 2 and 3
Answer: (b)
Statement 1 is incorrect because biofortification includes both conventional breeding and genetic engineering; not all biofortified crops are genetically engineered. Statements 2 and 3 are correct as ICAR has developed over 70 biofortified varieties and states adopting them have seen malnutrition reduction (NFHS-5, 2021-22).
✍ Mains Practice Question
Discuss how the biotechnology industry contributes to enhancing human and animal nutrition in India. What are the key regulatory challenges faced by the sector, and how can they be addressed to improve food security sustainably? (250 words)
250 Words15 Marks
What is the role of the Genetic Engineering Appraisal Committee (GEAC) in biotechnology regulation?

GEAC is the apex regulatory body under the Ministry of Environment, Forest and Climate Change responsible for approving activities involving genetically engineered organisms, including crops and feed additives. It ensures biosafety compliance under the Rules, 1989, and the Environment Protection Act, 1986.

How does biofortification improve human nutrition?

Biofortification enhances the micronutrient content of staple crops through conventional breeding or genetic engineering, addressing deficiencies like iron, zinc, and vitamin A. ICAR has developed over 70 such varieties, contributing to reduced malnutrition rates in adopting states.

What is the significance of the Food Safety and Standards Authority of India (FSSAI) in nutraceutical regulation?

FSSAI sets and enforces safety and quality standards for food products and nutraceuticals in India, ensuring consumer protection and compliance with the Food Safety and Standards Act, 2006.

How has the animal feed supplements market contributed to livestock productivity?

Animal feed supplements incorporating probiotics and enzymes have increased livestock productivity by 12% in India, improving animal health and efficiency, as reported by CRISIL in 2023.

What are the key economic indicators of India's biotech nutrition sector?

India’s biotech industry was valued at USD 84 billion in 2023 with a CAGR of 16.5%. The nutraceuticals segment is USD 7 billion growing at 20% annually, and animal feed additives are projected at USD 3.5 billion by 2025. Exports of biotech-derived nutraceuticals and feed supplements grew 18% in FY23.

Our Courses

72+ Batches

Our Courses
Contact Us